Anhui Deep Blue Medical Technology

Anhui Deep Blue Medical Technology is a Chinese medical technology company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) products. Founded in 2010 and based in Hefei, the company focuses on rapid diagnostic tests utilizing colloidal gold and fluorescence immunochromatography platforms. Their extensive product line covers several key areas, including gynecology and obstetrics, infectious diseases, oncology screening, and drug of abuse testing. Deep Blue Medical gained significant international prominence for its COVID-19 antigen rapid tests, which received CE certification and were exported globally. The company operates under strict quality management systems, including ISO 13485, and maintains a strong presence in both domestic and international diagnostic markets.